Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Perspectives on Artificial Intelligence in Dermatology: An International Cross-Sectional Study
0
Zitationen
18
Autoren
2026
Jahr
Abstract
Background and Objectives: Artificial intelligence (AI) has transitioned to an integral part of dermatology in only few years, yet perceptions of its use vary widely, reflecting diverse hopes, concerns, and perceived clinical utility. Materials and Methods: In this study, 300 dermatologists from 13 countries, representing a range of experience levels and AI usage statuses, were surveyed regarding the characteristics and applications of AI in dermatology. Results: Among respondents, 61.33% reported having used AI tools in clinical practice. Adoption of AI was observed across all age groups, countries, and experience levels. Analysis of the types of AI tools used revealed a strong reliance on general-purpose large language models (LLMs), with chatbots being the most frequently cited category, utilized by 58.15% of users. Younger clinicians demonstrated a significant preference for chatbots (p < 0.05). Country-specific patterns in AI adoption were also noted. The most highly rated expected benefit of AI in dermatology was improved diagnostic accuracy, while the primary concern centered on regulatory and ethical limitations, suggesting that the “AI revolution” in dermatology is currently constrained less by technical barriers and more by regulation considerations. Use of consent forms when AI use takes place was more frequently reported as mandatory by dermatologists who had never used AI, reflecting heightened caution among non-users (p = 0.03). Additionally, 75% of respondents agreed that formal training in AI is necessary, highlighting a significant gap in traditional medical education regarding emerging technologies.
Ähnliche Arbeiten
Dermatologist-level classification of skin cancer with deep neural networks
2017 · 13.434 Zit.
Tumor Angiogenesis: Therapeutic Implications
1971 · 10.108 Zit.
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
2011 · 7.666 Zit.
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 · 4.558 Zit.
Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma
1992 · 4.401 Zit.
Autoren
Institutionen
- University of Thessaly(GR)
- Aristotle University of Thessaloniki(GR)
- University Hospital of Larissa(GR)
- National and Kapodistrian University of Athens(GR)
- Andreas Sygros Hospital(GR)
- University of Gothenburg(SE)
- Ankara University(TR)
- Pontificia Universidad Católica de Chile(CL)
- All India Institute of Medical Sciences Bhubaneswar(IN)
- Nnamdi Azikiwe University(NG)
- Nnamdi Azikiwe University Teaching Hospital(NG)
- Royal New Zealand College of General Practitioners(NZ)
- Chinese Academy of Medical Sciences & Peking Union Medical College(CN)
- Peking Union Medical College Hospital(CN)
- Frauenklinik an der Elbe(DE)
- Hospital Venereal and Skin Diseases Thessaloniki(GR)
- Heliodor Swiecicki Clinical Hospital(PL)
- University of Udine(IT)